Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0R7AK
|
||||
Former ID |
DIB014382
|
||||
Drug Name |
CP-601927
|
||||
Synonyms |
CP-601932; Alpha4beta2 nAchR partial agonists (depression), Pfizer
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Gastrointestinal disease [ICD10:K00-K93] | Phase 2 | [522995] | ||
Company |
Pfizer Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C12H12F3N
|
||||
Canonical SMILES |
C1C2CNCC1C3=C2C=CC(=C3)C(F)(F)F
|
||||
InChI |
1S/C12H12F3N/c13-12(14,15)9-1-2-10-7-3-8(6-16-5-7)11(10)4-9/h1-2,4,7-8,16H,3,5-6H2/t7-,8+/m1/s1
|
||||
InChIKey |
RNOBTWYQAWEZHH-SFYZADRCSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Nicotinic ACh receptor alpha 4/beta 2 | Target Info | Modulator | [531488] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.